Simple and Practical Way of Assessing Diastolic Function: Diastolic Heart Failure Revisited

Dae-Won Sohn1,2

  • 1Division of Cardiology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

Korean Circulation Journal
|February 18, 2025
PubMed

Insights

The term heart failure with preserved ejection fraction (HFpEF) is often used instead of diastolic heart failure (DHF). Current methods for assessing diastolic function are complex, necessitating simpler diagnostic approaches for better clinical trial and practice application.

Area of Science:

  • Cardiology
  • Clinical Medicine

Background:

  • The term 'heart failure with preserved ejection fraction' (HFpEF) is now more common than 'diastolic heart failure' (DHF).
  • HFpEF focuses on ejection fraction, overlooking the hemodynamic mechanisms crucial for understanding diastolic heart failure.
  • Prognosis in HFpEF is primarily linked to underlying etiologies, complicating drug trial interpretations focused on survival benefits.

Purpose of the Study:

  • To highlight the limitations of the term HFpEF in fully capturing the essence of diastolic heart failure.
  • To advocate for a shift in focus for HFpEF studies towards specific etiologies and symptom improvement rather than survival.
  • To underscore the clinical need for a simplified and practical method for assessing diastolic function.

Main Methods:

  • Comparative analysis of terminology and diagnostic implications in heart failure research.
  • Review of current recommendations for evaluating diastolic function.
  • Discussion of challenges in applying complex diagnostic criteria in clinical trials and practice.

Main Results:

  • The term HFpEF inadequately represents the multifaceted nature of DHF.
  • Current diastolic function assessment guidelines are too complex for widespread clinical trial enrollment and daily practice.
  • The lack of simple assessment tools hinders effective research and patient management in DHF.

Conclusions:

  • Research and drug trials in HFpEF should focus on patients with confirmed diastolic dysfunction and prioritize symptom improvement.
  • There is a significant clinical need for developing and implementing simpler, practical methods for assessing diastolic function.
  • Revisiting the terminology and diagnostic approaches for diastolic heart failure is essential for advancing patient care and research.